tiprankstipranks
Dong Wha Pharm Co., Ltd. (KR:000020)
:000020
South Korea Market

Dong Wha Pharm Co., Ltd. (000020) Financial Statements

Followers

Dong Wha Pharm Co., Ltd. Financial Overview

Dong Wha Pharm Co., Ltd.'s market cap is currently ₩143.30B. The company's EPS TTM is ₩; its P/E ratio is 7.88; and it has a dividend yield of 4.77%. Dong Wha Pharm Co., Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 496.39B₩ 464.87B₩ 361.11B₩ 340.43B₩ 293.02B
Gross Profit₩ 203.33B₩ 214.26B₩ 190.42B₩ 180.99B₩ 149.35B
Operating Income₩ -809.25M₩ 13.41B₩ 25.30B₩ 29.92B₩ 22.50B
EBITDA₩ 21.16B₩ 28.72B₩ 48.74B₩ 38.23B₩ 39.41B
Net Income₩ 8.69B₩ 5.56B₩ 27.44B₩ 20.38B₩ 17.87B
Balance Sheet
Cash & Short-Term Investments₩ 24.34B₩ 43.50B₩ 88.83B₩ 107.69B₩ 121.51B
Total Assets₩ 642.17B₩ 619.63B₩ 564.97B₩ 461.14B₩ 447.80B
Total Debt₩ 118.41B₩ 96.99B₩ 47.10B₩ 6.66B₩ 11.47B
Net Debt₩ 105.11B₩ 71.33B₩ -25.22B₩ -27.68B₩ -49.01B
Total Liabilities₩ 240.55B₩ 217.96B₩ 157.92B₩ 82.46B₩ 87.67B
Stockholders' Equity₩ 379.53B₩ 373.37B₩ 371.78B₩ 364.40B₩ 346.93B
Cash Flow
Free Cash Flow₩ -37.48B₩ -78.07B₩ 2.82B₩ 9.13B₩ 11.26B
Operating Cash Flow₩ 15.70B₩ -4.00B₩ 29.17B₩ 29.22B₩ 36.03B
Investing Cash Flow₩ -41.18B₩ -74.79B₩ 2.86B₩ -43.27B₩ -25.41B
Financing Cash Flow₩ 13.40B₩ 31.36B₩ 5.87B₩ -12.01B₩ -8.78B
Currency in KRW

Dong Wha Pharm Co., Ltd. Earnings and Revenue History

Dong Wha Pharm Co., Ltd. Debt to Assets

Dong Wha Pharm Co., Ltd. Cash Flow

Dong Wha Pharm Co., Ltd. Forecast EPS vs Actual EPS